Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Jan 29, 2025

Total Value: $253M (100.0% shares, 0.0% debt)

Holdings (8)

ULCC FRONTIER GROUP HLDGS INC 79.0%

Value $200M Shares 28,061,351 Est. Cost $5.99 Unrealized +4.1%

RLX RLX TECHNOLOGY INC 15.4%

Value $38.98M Shares 18,046,195 Est. Cost $4.05 Unrealized —

ALLO ALLOGENE THERAPEUTICS INC 2.5%

Value $6.221M Shares 2,920,787 Est. Cost $17.44 Unrealized -85.9%

URGN UROGEN PHARMA LTD 2.1%

Value $5.278M Shares 495,606 Est. Cost $34.01 Unrealized -64.8%

— KRONOS BIO INC 0.5%

Value $1.233M Shares 1,297,959 Est. Cost $29.87 Unrealized —

GTLB GITLAB INC 0.3%

Value $642K Shares 11,399 Est. Cost $58.30 Unrealized 0.0%

PCOR PROCORE TECHNOLOGIES INC 0.2%

Value $607K Shares 8,095 Est. Cost $70.94 Unrealized 0.0%

— SILEXION THERAPEUTICS CORP 0.1%

Value $228K Shares 113,428 Est. Cost $2.01 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ULCC	FRONTIER GROUP HLDGS INC	28,061,351	$200M	79.0%	$5.99	+4.1%	COM	35909R108
RLX	RLX TECHNOLOGY INC	18,046,195	$38.98M	15.4%	$4.05	—	SPONSORED ADS	74969N103
ALLO	ALLOGENE THERAPEUTICS INC	2,920,787	$6.221M	2.5%	$17.44	-85.9%	COM	019770106
URGN	UROGEN PHARMA LTD	495,606	$5.278M	2.1%	$34.01	-64.8%	COM	M96088105
—	KRONOS BIO INC	1,297,959	$1.233M	0.5%	$29.87	—	COM	50107A104
GTLB	GITLAB INC	11,399	$642K	0.3%	$58.30	0.0%	CLASS A COM	37637K108
PCOR	PROCORE TECHNOLOGIES INC	8,095	$607K	0.2%	$70.94	0.0%	COM	74275K108
—	SILEXION THERAPEUTICS CORP	113,428	$228K	0.1%	$2.01	—	SHS NEW	G1281K122